e-learning
resources
Munich 2014
Sunday, 07.09.2014
Critical illness and therapeutic interventions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
M. R. Holger, K. Ute, T. Tschernig, S. Wienhold, M. Polikarpova, K. Hellwig, A. Vater, C. Maasch, S. Klussmann, M. Menger, N. Suttorp, M. Witzenrath (Berlin, Homburg, Germany)
Source:
International Congress 2014 – Critical illness and therapeutic interventions
Session:
Critical illness and therapeutic interventions
Session type:
Oral Presentation
Number:
1385
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. R. Holger, K. Ute, T. Tschernig, S. Wienhold, M. Polikarpova, K. Hellwig, A. Vater, C. Maasch, S. Klussmann, M. Menger, N. Suttorp, M. Witzenrath (Berlin, Homburg, Germany). Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis. Eur Respir J 2014; 44: Suppl. 58, 1385
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Methotrexate reduces acute lung injury in a murine model of sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016
Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
Ventilator-induced lung injury in severe pneumococcal pneumonia: Protection by adrenomedullin
Source: Annual Congress 2012 - Novel mechanisms of acute lung injury
Year: 2012
Effects of nebulized heparin on pulmonary inflammation in a rat model of acute lung injury
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia
Source: Annual Congress 2013 –Interesting research questions
Year: 2013
Neutrophilia is associated with the persistent parenchymal changes after acute lung injury
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
CD4 as a predictor of systemic inflammatory response and death at severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Arterial oxygen content could reflect acute organ damage in community-acquired pneumonia
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Vasculotide reduced pulmonary hyperpermeability in pneumococcal pneumonia
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016
Acute lung injury and ventilator-associated pneumonia: introduction
Source: Eur Respir J 2003; 22: 1S
Year: 2003
A mouse model of acute lung injury implicates phospholipase Cε in neutrophilic inflammation through CXC chemokine production
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
Down-regulation of RIP140 can prevent LPS-induced inflammation and acute lung injury in mice via PPARγ
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Oral inhalation of AP301 peptide activates pulmonary oedema clearance: Initial results from a phase IIa clinical trial in mechanically ventilated ICU patients
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014
Snake venom leads to injury similar to acute lung injury revealing the needing of anti-inflammatory therapy
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Smoking status and respiratory infections during mechanical ventilation
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Proton-sensing TDAG8 exhibits the protective role in lipopolysaccharide-induced acute lung injury
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016
The role of SIRT1 in LPS-induced lung endothelial barrier dysfunction and lung injury in vivo
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
LATE-BREAKING ABSTRACT: Human mesenchymal stem cell exosomes attenuates sepsis-induced acute lung injury via inhibition of oxidative stress and the MAPK-NF-?B pathway
Source: International Congress 2015 – Acute critical care: mechanical ventilation: how to limit the damage
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept